# Teva Canada Limited, Scarborough, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/teva-canada-limited/6a370eba-92cd-4be4-81d9-c4f4033f3f4f

> Inspection records and compliance data for Teva Canada Limited in Scarborough. 7 FDA inspections on record, last inspected November 10, 2023.

---

## Details

- Name: Teva Canada Limited
- FEI Number: 3002807756
- Canada Business Number: 885106765RC0005
- Business Operations: API/FDF ANALYTICAL TESTING, PACK
- Address Line 1: 30 Novopharm Crt
- City: Scarborough
- Country Name: Canada
- Address: 30 Novopharm Crt, Scarborough, Canada
- Country: Canada

## Related Documents

- Canada Inspection - Teva Canada Limited - Inspection #86082 - 2025-03-04 — source: Canada, date: March 4, 2025
- Canada Inspection - Teva Canada Limited - Inspection #86081 - 2025-02-25 — source: Canada, date: February 25, 2025
- Canada Inspection - Teva Canada Limited - Inspection #84030 - 2024-07-15 — source: Canada, date: July 15, 2024
- FDA Inspection 1224785 - Teva Canada Limited - 2023-11-10 — classification: No Action Indicated (NAI), source: FDA, date: November 10, 2023
- Canada Inspection - Teva Canada Limited - Inspection #82277 - 2023-11-06 — source: Canada, date: November 6, 2023
- Canada Inspection - Teva Canada Limited - Inspection #77963 - 2022-01-10 — source: Canada, date: January 10, 2022
- Canada Inspection - Teva Canada Limited - Inspection #77834 - 2021-12-06 — source: Canada, date: December 6, 2021
- Canada Inspection - Teva Canada Limited - Inspection #77169 - 2021-08-16 — source: Canada, date: August 16, 2021
- Canada Inspection - Teva Canada Limited - Inspection #73398 - 2019-12-03 — source: Canada, date: December 3, 2019
- Canada Inspection - Teva Canada Limited - Inspection #73386 - 2019-11-26 — source: Canada, date: November 26, 2019
- [FDA Inspection 1107481 - Teva Canada Limited - 2019-10-25](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/aef8bac3-86c8-412a-a631-33bb71095ab3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2019
- FDA Inspection 1038516 - Teva Canada Limited - 2017-12-14 — classification: No Action Indicated (NAI), source: FDA, date: December 14, 2017
- FDA Inspection 961307 - Teva Canada Limited - 2016-02-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2016
- FDA Inspection 838128 - Teva Canada Limited - 2013-05-24 — classification: No Action Indicated (NAI), source: FDA, date: May 24, 2013
- FDA Inspection 749939 - Teva Canada Limited - 2011-09-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2011
- FDA Inspection 566481 - Teva Canada Limited - 2009-02-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 27, 2009

## Related Companies

- [Taro Pharmaceuticals Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768)
- [Baxter Corporation](https://www.keypedia.com/companies/baxter-corporation/ca56a675-623d-4cdd-9810-05ae4ba274e0)
- [Lernapharm (Loris) Inc.](https://www.keypedia.com/companies/lernapharm-loris-inc/2321aaaa-6f7e-4dc9-9c7e-09593fa9efda)
- [Pharmascience Inc.](https://www.keypedia.com/companies/pharmascience-inc/2fa6f1e7-a980-4d37-b8d0-daf9e3a309c4)
- [Bausch Health Companies Inc.](https://www.keypedia.com/companies/bausch-health-companies-inc/3190f4ed-695e-491f-a57e-1ef128f7e2af)
- [Duchesnay Inc.](https://www.keypedia.com/companies/duchesnay-inc/b48797ea-bce2-4e75-a2cd-4e6b3a5f722c)
- [Diversey Canada, Inc.](https://www.keypedia.com/companies/diversey-canada-inc/08a08842-7884-4417-bc84-a625d0dae16d)
- [Odan Laboratories Ltd](https://www.keypedia.com/companies/odan-laboratories-ltd/00e302de-b81d-482e-b486-cf23e1cd0747)
- [Kenvue Canada Inc.](https://www.keypedia.com/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)
- [Halo Pharmaceutical Canada Inc](https://www.keypedia.com/companies/halo-pharmaceutical-canada-inc/1f4cfadf-e895-4fd7-a813-959f505dd7ce)